Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Sius single-use tangential flow filtration skid from Novasep

Novasep, a leading supplier of manufacturing solutions to the life sciences industries, today announces the launch of its Sius single-use tangential flow filtration (TFF) skid.

26 Feb 2013

Xellia to develop new antibiotics effective against multi-drug resistant Gram-negative bacteria

Xellia Pharmaceuticals, a fully integrated specialty pharmaceutical company focusing on the global anti-infective market, announced today that it is developing new antibiotics effective against multi-drug resistant (MDR), Gram-negative bacteria.

26 Feb 2013

Glide Pharma announces completion of $21.4 million investment round

Glide Pharma, the pharmaceutical development and device company focused on the needle-free administration of solid dose formulations, today announced that it has completed a £14.0 million ($21.4 million) investment round.

26 Feb 2013

Comprehensive portfolio of antiretroviral products from Mylan

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.

25 Feb 2013

EnvisionTEC launches 3Dent for manufacture of dental models

EnvisionTEC, a leading manufacturer and distributor of patented 3D rapid prototyping and manufacturing solutions, unveiled the newest addition to its dental lineup, 3Dent, specifically for the manufacture of dental models.

23 Feb 2013

Blaze Bioscience completes $8.5 million Series A financing

Blaze Bioscience, Inc., a biotechnology company dedicated to developing innovative products to improve the lives of cancer patients, today announced the completion of a Series A financing totaling $8.5 million and bringing the total funds raised since inception to $9.8 million.

22 Feb 2013

IntegraGen, Lab21 collaborate to develop new microRNA assay for colorectal cancer

Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes.

22 Feb 2013

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Breast cancer is a major concern throughout the world. It is the number 1 cancer among women and in the Western world it generates approximately one new case per minute: 24 hours a day 7 days a week.

22 Feb 2013

Sucampo launches RESCULA Eye Drops in the U.S.

Sucampo Pharmaceuticals, Inc. announced that RESCULA Eye Drops had been launched in the U.S. market.

21 Feb 2013

Ipsen, Inspiration Biopharmaceuticals sell IB1001 hemophilia B product to Cangene

Inspiration Biopharmaceuticals and Ipsen today announced the closing of the sale of the proprietary hemophilia B product, IB1001 (recombinant FIX), to Cangene Corporation.

20 Feb 2013

Oncolytics Biotech to commence underwritten public offering of common shares

Oncolytics Biotech Inc. announced today its intention, subject to market and other conditions, to commence an underwritten public offering of common shares. The number of common shares to be distributed and the price of each common share will be determined in the context of the market with final terms to be determined at the time of pricing.

19 Feb 2013

Otolaryngology, head and neck surgery: an interview with Thomas Cherry, Cook Medical

Cook Medical is the world’s largest privately held medical device manufacturer. The ENT division is Cook’s 10th business unit/clinical division and we are excited to meet the needs of ENT patients.

From COOK MEDICAL INC. 18 Feb 2013

Dietary impacts, health changes and oral pathogen genomic evolution

DNA preserved in calcified bacteria on the teeth of ancient human skeletons has shed light on the health consequences of the evolving diet and behaviour from the Stone Age to the modern day.

18 Feb 2013

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

U.S. Marshals, acting on behalf of the U.S. Food and Drug Administration, today seized tainted dietary supplements from Globe All Wellness, LLC (Globe All), in Hollywood, Fla. The products may be unsafe because they contain an undisclosed active pharmaceutical ingredient.

15 Feb 2013

IOM proposes state, FDA actions to stop growth of counterfeit drugs

The Institute of Medicine Wednesday urged a series regulatory changes to help protect the public against buying fake or poorly made drugs.

15 Feb 2013

Viewpoints: FDA needs more power to regulate compounding pharmacies; Time to revamp military benefits, including health

Traditionally, the licensing and control of pharmacies has been left to the states, but their performance has been uneven. The federal role has been thrown into question in recent years by lawsuits. ... compounding pharmacies are not generally required to inform the FDA that they are in business nor to register with the FDA or disclose what products they are making.

15 Feb 2013

Cambrex, Dow partner to manufacture HPMCAS for drug solubility enhancement

Cambrex and The Dow Chemical Company have executed an agreement for Cambrex to contract manufacture Dow Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) for Drug Solubility Enhancement.

15 Feb 2013

Roundup: States get insurance exchange weapon on abortion; N.Y. budget woes include Medicaid money worry; Ga. hospital 'bed tax' might not offer budget solution

Abortion opponents have found a new way to restrict access to abortion -- by using the authority states have over the new health insurance exchanges, which will be up and running in a year. At least 21 states have legislation in place or in the works that will stop health insurance companies from paying for abortions for women.

15 Feb 2013

Tianyin Pharmaceutical second quarter revenue decreases 3.3% to $17.6 million

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for second quarter of the fiscal year 2013.

14 Feb 2013

New paper advances scientific understanding of glycoproteins’ structure and function

A Simon Fraser University chemist is the lead author on a new paper that advances scientific understanding of the structure and function of glycoproteins, in particular the number and positioning of sugars on them.

14 Feb 2013

Manufacturing News and Research

Further Reading

Sius single-use tangential flow filtration skid from Novasep

Xellia to develop new antibiotics effective against multi-drug resistant Gram-negative bacteria

Glide Pharma announces completion of $21.4 million investment round

Comprehensive portfolio of antiretroviral products from Mylan

EnvisionTEC launches 3Dent for manufacture of dental models

Blaze Bioscience completes $8.5 million Series A financing

IntegraGen, Lab21 collaborate to develop new microRNA assay for colorectal cancer

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Sucampo launches RESCULA Eye Drops in the U.S.

Ipsen, Inspiration Biopharmaceuticals sell IB1001 hemophilia B product to Cangene

Oncolytics Biotech to commence underwritten public offering of common shares

Otolaryngology, head and neck surgery: an interview with Thomas Cherry, Cook Medical

Dietary impacts, health changes and oral pathogen genomic evolution

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

IOM proposes state, FDA actions to stop growth of counterfeit drugs

Viewpoints: FDA needs more power to regulate compounding pharmacies; Time to revamp military benefits, including health

Cambrex, Dow partner to manufacture HPMCAS for drug solubility enhancement

Roundup: States get insurance exchange weapon on abortion; N.Y. budget woes include Medicaid money worry; Ga. hospital 'bed tax' might not offer budget solution

Tianyin Pharmaceutical second quarter revenue decreases 3.3% to $17.6 million

New paper advances scientific understanding of glycoproteins’ structure and function

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy